BrightPath Biotherapeutics4594 
$0.36-1.92%24h
-1.92%24h
Global rank29457
Market cap$21.41M
Change 7d0.00%
YTD Performance-40.70%
SP500 benchmarkUnderperform
P/E-0.01
P/S576.26
Revenue$37.16K
Earnings-$10.45M
Dividend yield-
BrightPath Biotherapeutics 4594 Operating Margins
Operating Margin in 2022: -277.85%
According to BrightPath Biotherapeutics latest financial reports the company has an operating margin of -277.85%, an increase of 190.04% to 2022. At the end of 2022 company had an operating margin of -95.80%.
BrightPath Biotherapeutics Operating Margin from 2020 to 2024
-
Value:-
4594 Operating Margin History by year
| Year | Operating Margin | Change |
|---|---|---|
| 2023 | -277.85% | 190.04% |
| 2022 | -95.80% | -86.16% |
| 2021 | -692.01% | 327.93% |
| 2020 | -161.71% | - |
View the highest operating margin companies 
